Understanding Corticotropin Releasing Factor Receptor (CRFR) Activation Using Structural Models

被引:0
|
作者
Cordomi, Arnau [1 ]
Liapakis, George [2 ]
Matsoukas, Minos-Timotheos [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Unitat Bioestat, Lab Med Computac, Bellaterra 08193, Barcelona, Spain
[2] Univ Crete, Fac Med, Dept Pharmacol, Iraklion 71003, Crete, Greece
[3] Univ Patras, Lab Mol Pharmacol, Dept Pharm, Patras 26500, Greece
关键词
Activation; corticotropin releasing factor; family B; GPCR structure; molecular modeling; CRF receptors; PROTEIN-COUPLED RECEPTOR; 2ND TRANSMEMBRANE HELIX; 1ST EXTRACELLULAR DOMAIN; CLASS-B GPCRS; LIGAND-BINDING; ANTAGONIST-BINDING; CRYSTAL-STRUCTURE; NMR STRUCTURE; PEPTIDE; FAMILY;
D O I
10.2174/187446/7210666170110122939
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The corticotropin-releasing factor type 1 and 2 receptors (CRF1R and CRF2R) belong to the secretin-like family, also known as class B1, of G protein-coupled receptors (GPCRs). Several endogenous hormones mediate their responses through the CRF receptors, such as CRF and the urocortins. The structures for the N-terminus extracellular domain of both CRF1R and CRF2R in complex with peptidic ligands were released a few years ago and permitted the study of hormone binding to the orthosteric binding site. Until the crystal structure of the transmembrane domain of human CRF1R in its inactive state bound to an allosteric antagonist became available. Together with the crystal structures of the transmembrane domain of the glucagon receptor (GCGR), they have enabled the structural alignment between the rhodopsin and secretin-like families, which permits the direct comparison of the functional domains in both classes. In this report, we review the current structural landscape, in addition to the knowledge regarding activation of both CRF receptors and the generalization to secretin-like GPCRs in general. Thus, significant effort was put in trying to identify possible analogous microswitches in the class B1, with the hypothesis that both families could maintain a similar arrangement of their functional domain.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [31] The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress
    Henry, Brook
    Vale, Wylie
    Markou, Athina
    JOURNAL OF NEUROSCIENCE, 2006, 26 (36): : 9142 - 9152
  • [32] Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor
    Hamke, Maike
    Herpfer, Inga
    Lieb, Klaus
    Wandelt, Carolin
    Fiebich, Bernd L.
    BRAIN RESEARCH, 2006, 1102 : 135 - 144
  • [33] Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior
    Bale, TL
    Picetti, R
    Contarino, A
    Koob, GF
    Vale, WW
    Lee, KF
    JOURNAL OF NEUROSCIENCE, 2002, 22 (01): : 193 - 199
  • [34] RECEPTOR-MEDIATED ACTIVATION OF TYROSINE-HYDROXYLASE BY CORTICOTROPIN-RELEASING FACTOR IN STRIATAL SYNAPTOSOMES
    OLIANAS, MC
    ONALI, P
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (12): : 1097 - 1098
  • [35] Activation of Corticotropin-Releasing Factor Receptor 2 in Lateral Septum Negatively Regulates Maternal Defense
    D'Anna, Kimberly L.
    Gammie, Stephen C.
    BEHAVIORAL NEUROSCIENCE, 2009, 123 (02) : 356 - 368
  • [36] Corticotropin-Releasing Factor Acting on Corticotropin-Releasing Factor Receptor Type 1 is Critical for Binge Alcohol Drinking in Mice
    Kaur, Simranjit
    Li, Ju
    Stenzel-Poore, Mary P.
    Ryabinin, Andrey E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (02) : 369 - 376
  • [37] Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides (vol 47, pg 3450, 2004)
    Mazur, AW
    Wang, F
    Tscheiner, M
    Donnelly, E
    Isfort, RJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) : 7502 - 7502
  • [38] Understanding corticotropin releasing factor neurobiology: contributions from mutant mice
    Contarino, A
    Heinrichs, SC
    Gold, LH
    NEUROPEPTIDES, 1999, 33 (01) : 1 - 12
  • [39] Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia
    Tezval, H.
    Merseburger, A. S.
    Seidler, M.
    Serth, J.
    Kuczyk, M. A.
    Oelke, M.
    UROLOGE, 2008, 47 (09): : 1079 - +
  • [40] Structural-Functional Analysis of the Third Transmembrane Domain of the Corticotropin-releasing Factor Type 1 Receptor ROLE IN ACTIVATION AND ALLOSTERIC ANTAGONISM
    Spyridaki, Katerina
    Matsoukas, Minos-Timotheos
    Cordomi, Arnau
    Gkountelias, Kostas
    Papadokostaki, Maria
    Mavromoustakos, Thomas
    Logothetis, Diomedes E.
    Margioris, Andrew N.
    Pardo, Leonardo
    Liapakis, George
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (27) : 18966 - 18977